Nateglinide (INN trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto a Japanese company and sold by the Swiss pharmaceutical company Novartis.Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs.
This page contains content from the copyrighted Wikipedia article "Nateglinide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
